About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Friday, June 16th, 2017

The QualityStocks
Daily Stock List


MEDITE Cancer Diagnostics, Inc. (MDIT)

Wall Street Mover reported on MEDITE Cancer Diagnostics, Inc. (MDIT), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

MEDITE Cancer Diagnostics, Inc. is a medical technology company headquartered in Orlando, Florida. It specializes in the development, engineering, manufacturing, and marketing of premium medical devices and consumables. These are for detection, risk assessment, and also diagnosis of cancer and related disease. The Company has a presence in 70 global markets.

MEDITE Cancer Diagnostics is a Delaware registered company consisting of wholly-owned MEDITE GmbH a Germany-based company with its subsidiaries. The Company formerly went by the name CytoCore, Inc. It changed its corporate name to MEDITE Cancer Diagnostics, Inc. in December 2014. The Company lists on the OTC Markets Group’s OTCQB.

MEDITE’s exclusive focus is on unique solutions for cancer diagnostics. The Company is a leading developer and manufacturer of innovative, high-quality equipment and supplies for histology, pathology, and cytology laboratories. Additionally, MEDITE engages in the design, development, and commercialization of cost-effective cancer screening systems and Biomarkers to assist in the early detection of cancer.

MEDITE has a complete range of Histology and Cytology lab equipment and supplies. Its emphasis is on attractive market-and product segments characterized by one or two players. As a result, there is room for Company market share growth.

MEDITE offers USE33, an ultrasonic decalcification instrument that automatically runs the process under controlled temperatures; TPC15 Duo or Trio; TES99; TES Valida; M530; A550; M380; TST44; COT20 linear staining systems; and RCM9000, ACS720, and TWISTER glass and robotic coverslippers.

In addition, the Company provides the SoftPAP device for the collection of cervical cell samples used in the detection of cervical dysplasia, cancer, and human papillomavirus infections. MEDITE also develops the SoftKit device for the self-collection of a sample that can undergo evaluation to provide an assessment of the health of the entire female genital tract; BreastPap breast cancer risk assessment devices; and SureThin and SafePrep products.

Last month, MEDITE Cancer Diagnostics announced further restructuring of its organization in Germany to position the Company for revenue growth and profitability. Mr. David Patterson, Chief Executive Officer of the Company, said, "This new organization is executing plans to increase MEDITE's market presence short term within the core business, commercialize new offerings from MEDITE's R&D teams in the U.S. and Germany, and ensure the launch of new products for China in 2017. These actions allow MEDITE to gain a secure financial footing and realize its charter as a leading provider of cancer diagnostic products."

MEDITE Cancer Diagnostics, Inc. (MDIT), closed Friday's trading session at $0.50, even for the day, on 19 volume with 2 trades. The average volume for the last 60 days is 3,070 and the stock's 52-week low/high is $0.26/$0.8949.

Petrone Worldwide, Inc. (PFWI)

SmallCapFinancialWire reported earlier on Petrone Worldwide, Inc. (PFWI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Petrone Worldwide, Inc. is a leader in the hospitality industry with worldwide operations abilities. The Company’s Founder, Mr. Victor Petrone, has spent more than two decades building a considerable international network of institutional hospitality industry buyers (hotels, resorts, and restaurants). Petrone Worldwide is the exclusive importer and distributor for renowned brands. It focuses as an importer and distributor throughout Europe and India for hospitality solutions for the finest hotels, restaurants, and design firms globally. The Company provides the hospitality industry an eclectic mix of materials and stylish product options. Petrone Worldwide is based in Weston, Florida.

The Company provides third party logistics for overseas manufacturing companies endeavoring to sell their goods in North America. Also, Petrone Worldwide sells and markets products under its own proprietary name. The Company also acts as distributor for a wide array of companies to the hospitality trade.

Petrone Worldwide imports, exports, and distributes tableware products, decorative hotel guest room amenities, lavatory, bathroom fixtures and furniture, food and beverage service items, and popular accessories for the Asian and European markets. Its businesses additionally include Petrone Food Works (PFW). PFW can facilitate the total process from manufacturing plant to end-user into the worldwide marketplace.

Petrone’s businesses also include Petrone Hospitality Group. This business is the exclusive distributor for commercial grade tabletop, guest and bathroom, for the Asian and European marketplaces for Front of House, Room 360, and Dewan & Sons.

The Company’s businesses also include Petrone Dewan. This is its upstart in the logistics market. Petrone Worldwide is also expanding its food service disposables offering. It signed an agreement to acquire Transpower Component (India) Pvt. Ltd. via a share purchase agreement. Transpower Component is a top Indian manufacturer of Food Service disposable aluminum products.

Transpower’s collection includes steam table pans, rounds, squares, oblongs, ovals in an assortment of sizes with coordinating aluminum, and board lids. Roll foil is available in a variety of widths and lengths in both standard for Catering, Bakery, Carry Out and Food Processors.

Petrone Worldwide announced this past February that it is in the process of entering the cannabis market in the very near future. The Company will use their extensive knowledge of transportation and logistics to facilitate the international delivery of cannabis related products.

Moreover, in February, Petrone Worldwide announced that it formally signed a Letter of Intent (LOI) with Twisted Lab, LLC to become the exclusive distributor for their cannabis products across Europe. Petrone will also facilitate the building of a first-rate global sales and marketing distribution network throughout the sovereign states of Europe, which will be mutually beneficial for the Company and Twisted Lab. Twisted Lab is a leader in the cannabis market with its silicone water pipe line that will undergo distribution by Petrone Worldwide.

This week, Petrone Worldwide announced its official purchase of inventory to meet the growing demand in the European and India Marketplace. The new inventory will increase Company revenue for the next two quarters at a rate faster than Petrone had earlier projected.

Petrone Worldwide, Inc. (PFWI), closed Friday's trading session at $0.025, down 16.67%, on 343,990 volume with 24 trades. The average volume for the last 60 days is 127,403 and the stock's 52-week low/high is $0.0115/$1.00.

Mexus Gold US (MXSG)

SmallCapVoice, AllPennyStocks, 777 Stocks, Wall Street Reporter, FeedBlitz, OTC Picks, and Stock Guru reported previously on Mexus Gold US (MXSG), and we report on the Company today, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Mexus Gold US is a mining enterprise with holdings in Mexico. The Company’s properties include the fully-owned Santa Elena Mine. This property is 54km NW of Caborca, Mexico. The Santa Elena mine sits in a region that is now undergoing mining by some of the largest mining companies in the world. Founded in 2009, Mexus Gold US has its corporate headquarters in Carson City, Nevada.

Mexus has drill results that show a high-grade, multi vein system throughout the Santa Elena mine. The Company’s belief is that the Santa Elena mine has great potential and that a well- financed company will use the considerable work already completed to further the project.

In addition, Mexus owns rights to the Ures property positioned 80km N of Hermosillo, Mexico. The property contains 6900 acres and has gold and copper on the property.    

Mexus Gold US entered into a joint venture (JV) agreement with MarMar Holdings of Mexico at its Santa Elena mine.  Under the 50/50 JV agreement, MarMar will operate the mine and carry all costs.

Mexus Gold US announced in January 2017 that it determined to acquire the concessions comprising the San Felix Project.  The Company entered into land surface use agreements and concession purchase agreements for different land parcels, which expired under the previous owner’s failure to pay.

Furthermore, Mexus announced the execution of an agreement with MarMar Holdings where each company owns a 50 percent share of the San Felix Project and designates MarMar Holdings as the operator of the daily production activities. The San Felix mine in Northern Mexico is a 26,000-plus acre property. It is ready for production that is planned for 2018.

In April of this year, Mexus Gold US announced that on April 22nd, Chief Executive Officer Mr. Paul Thompson observed the first smelting of precipitate at its Santa Elena mine. Mr. Thompson said, “This test run went well resulting in a small amount of dore.  The crew will be fine tuning the temperature of the furnace, adjusting the flux mixture, and installing a more precise weighing system.  These are normal steps for a start-up and won’t take long to perfect. This is a hallmark moment for Mexus and marks what will be the first of many gold pours to come.”

Earlie this month, the Company announced that progress at the Santa Elena mine continues towards the objective of becoming a producing mine.  The Company’s geologist, Mr. Cesar Lemas, spent the last few weeks analyzing all aspects at the mine and produced a technical report that includes an operating plan.  The Santa Elena mine has processed 16,000 tons of ore from Vein 2, which was the blasted material to a depth of 5 meters.  New mineralized material is now being mined from the Julio structure.  A low angle shear zone has just been uncovered at the footwall of the main Julio vein. Assays at the Santa Elena mine show an average 5 g/t Au and 18 g/t Ag.

This week, Mexus Gold US announced that the secondary cone crusher arrived at the Santa Elena mine. The equipment will help the Company and its JV partner, MarMar Holdings, in reaching the end goal of producing 10,000 tons per day. 

Mexus Gold US (MXSG), closed Friday's trading session at $0.065, up 1.40%, on 530,170 volume with 40 trades. The average volume for the last 60 days is 537,063 and the stock's 52-week low/high is $0.043/$0.235.

LifeLogger Technologies Corp. (LOGG)

Cannabis Financial Network News, Wall Street Mover, Epic Stock Picks, EpicVIP Group, Beacon Equity Research, Penny Stock Craze, SuperStockTips, Stock Preacher, Penny Stocks Finder, InvestorSoup, Barchart, SuperNova Elite, TopStockAnalysts, and StreetAuthority Daily reported on LifeLogger Technologies Corp. (LOGG), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

LifeLogger Technologies Corp.’s commitment is to change the way people remember their life. The Company creates an innovative user experience through combining video, face, text, GPS map, and OCR and voice recognition. This is to make the digital story of one’s life richer, fuller, accessible, searchable, and memorable. Fundamentally a location smart media cloud service, LifeLogger Technologies is a unique wearable technology and software enterprise. The Company is based in Palm Beach Gardens, Florida and its shares trade on the OTC Markets’ OTCQB.

Furthermore, LifeLogger Technologies announced in July of 2016, that it completed the acquisition of key assets of Pixorial, Inc. With the terms of the Amended and Restated Asset Purchase Agreement, LifeLogger Technologies acquired certain assets of Pixorial, including the registered trademark “What’s Your Story?”® and the 620,000 customer list. Pixorial is a personal photo and video sharing platform.

LifeLogger Technologies is device agnostic. This permits one to use their iOS or Android device, or other wearable camera and/or sensor solutions. The Company has leading-edge technology that presents meaningful advanced search functionality. This includes geo-enabled location search and face detection.

LifeLogger has developed a Web APP software solution providing users the ability to capture, store, as well as live stream their memories. It is developing the new standard for people to record, store, and recall life's unique memories. This is achieved by way of its cloud based portal for video management, post video processing, easy search, live streaming, and social sharing.

LifeLogger Technologies is working on creating the ultimate life logging system, equipped with a cloud solution and metadata processing software. This will actively store a person’s memories and make them available on the web, desktop, and all of one’s mobile devices. The Company’s software seamlessly and automatically organizes videos by date, time, place or person on LifeLogger’s own 3D timeline when uploaded to its cloud based service.

LifeLogger, to launch its hardware and software platforms for commercial use, is finishing the hardware design of its LifeLogger wearable camera. It is working to complete the development of its video cloud storage solution featuring Android and IOS APP. In addition, it is finishing an open API to make it possible for other wearable cameras on the market to communicate with its cloud.

LifeLogger Technologies Corp. (LOGG), closed Friday's trading session at $0.047, up 2.17%, on 496,248 volume with 94 trades. The average volume for the last 60 days is 39,250 and the stock's 52-week low/high is $0.0225/$2.97.

PetLife Pharmaceuticals, Inc. (PTLF)

MicroCapDaily, OTCMagic, Winston Small Cap, Equity Observer, Value Penny Stocks, Jet-Life Penny Stocks, TopPennyStockMovers, PHUB News, DSR News, SixFigureStockPicks, Winning Penny Stock Picks, Penny Stock Circle, 1-2-3 Stock Alerts, StockMister, Fortune Stock Alerts, RisingPennyStocks, Super Hot Penny Stocks, PennyStockMoneyTrain, WePickPennyStocks, Liquid Tycoon, Penny Stock Pick Alert, Penny Stock Pick Report, PennyPickAlerts, Super Nova Stock Picks, Joe Penny Stocks, FOX Penny Stocks, Wall St Report, smartOTC, and OTC Markets Group reported on PetLife Pharmaceuticals, Inc. (PTLF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

PetLife Pharmaceuticals, Inc. is a developer of new generation high potency veterinary cancer medications and nutraceuticals for pets. PetLife is a registered US Veterinary Pharmaceutical company. The Company is a spinoff of Medolife Corp. and its management team comprises experts and professionals in the veterinary, business, sales and management fields.  PetLife Pharmaceuticals is headquartered in Hancock, Maryland.

The Company is launching a new generation of all natural veterinary cancer medications and nutraceuticals based on the venom of the Caribbean Blue Scorpion. The foundation of this treatment is on the same patented formula and production processes used in the human formulation called Escozine™.

PetLife Pharmaceuticals has licensed the worldwide rights to formulate, package, and market a new product line, "Vitalzul for Pets™". The Company’s mission is to bring several non-invasive treatments to market with the goal of improving the quality of life in companion animals. It states that expected registration of a Food and Drug Administration (FDA) approved drug, “Vitalzul™”, for the treatment of cancer in animals, and the introduction of nutraceuticals, food, and pet treats, are all in the works presently.

Vitalzul™ was originally developed and commercialized by PetLife™, Corp. in 2007. PetLife™ received a full patent in 2012. The exclusive patent license, (United States patent # 8,097,284 B2) is being used to produce a new generation of nutraceuticals and drugs using the polarized, potentiated bioactive peptide to cause apoptosis in malignant cells. Vitalzul™ is selling in the U.S. as a nutraceutical.

Last month, PetLife Pharmaceuticals announced that its subsidiary, Dr. Geoff's by PetLife, Inc., completed the acquisition of assets related to the natural pet food product line. The different trademarks supporting the Dr. Geoff's Real Food for Pets™ were acquired in exchange for common stock of PetLife Pharmaceuticals. The product line is projected to include VitalZul™ in a second generation of the product next year.

Furthermore, PetLife research has verified that scorpion venoms may also have antibacterial and anti-inflammatory properties. The PetLife research team is evaluating the potential for scorpion venom-based therapy for common companion pet diseases, including Lyme disease and arthritis.

Yesterday, PetLife Pharmaceuticals reported on its solution to the ever-growing problem of drug resistance and high toxicity in the treatment of cancer in pets and humans. The Company’s new patent-pending formulation has created a 'cancer cocktail' combining Blue Scorpion Venom Chlorotoxin with plant-based phytonutrients. Preliminary testing has shown inhibition against certain cancer cell line studies without toxicity.

Dr. Vivekananda Ramana, Chief Medical Officer of PetLife Pharmaceuticals, stated, "Our new formulation, RX002CxN, will become the basis of PetLife Pharmaceutical's new product portfolio, Vitalzul™ a novel treatment option for the treatment of cancer and potentially other indications. The low toxicity of our formulation gives additional benefit. Given the comparative biology of animals and humans, it is our hope that success in treatment of cancer in animals will lead to similar results in humans. Our new formulation has been designed with both human and animal applications in mind. Once testing is completed, the Company will strategically determine the best course of development in both the pet and human markets."

PetLife Pharmaceuticals, Inc. (PTLF), closed Friday's trading session at $0.2199, up 12.77%, on 103,733 volume with 39 trades. The average volume for the last 60 days is 69,433 and the stock's 52-week low/high is $0.08/$1.00.


The QualityStocks
Company Corner


Kootenay Zinc Corp. (CSE:ZNK) (OTCQB:KTNNF)

The QualityStocks Daily Newsletter would like to spotlight Kootenay Zinc Corp. (KTNNF). Today, Kootenay Zinc Corp. closed trading at $0.1186, up 27.53%, on 16,334 volume with 8 trades. The stock’s average daily volume over the past 60 days is 99,406, and its 52-week low/high is $0.0875/$0.59.

Kootenay Zinc Corp. provides the following update on exploration activities and upcoming drill testing at the Sully project. Field programs have continued through May and early June and the project team has completed a number of activities at the site, with a specific focus on the E3 Target: detailed gravity surveying, interpretation and mass modeling, prospecting and mapping, soil geochemistry sampling, drilling preparations and road/access preparations.

Kootenay Zinc Corp. (KTNNF) is a mineral exploration and development company focused on discovering large-scale sedimentary-exhalative ("SEDEX") zinc deposits. Based in Vancouver, British Columbia, the company is ideally positioned near its primary target, the Sully Property, located 18 miles east of the world-class Sullivan Mine.

Of the 22 raw materials tracked by the Bloomberg Commodity Index, zinc was the best-performing base metal in 2016. Based on a widening global supply deficit, outlook for the commodity remains strong. As the most closely tied base metal to the Chinese economy, zinc demand and prices are expected to rise well into the year 2020, putting increased pressure on zinc supply.

For 2017, Goldman Sachs has predicted a 360,000 ton shortage of zinc, along with a subsequent rise in zinc prices to $2,500 per metric ton in the first half of the year. Zinc continues to make history in the metals exchange, driving significant interest in the market amid supply constraints in concentrates and refined metal drive prices.

Ready to claim its share of the market, Kootenay Zinc is focused on its Sully Property. It comprises 1,375 hectares and overlies rocks of similar age and origin as those which host the legendary Sullivan deposit. The Sullivan mine was discovered in 1892, and is known to be one of the world's largest SEDEX deposits. Over its 100-year lifetime, Sullivan produced approximately 150 million tonnes of ore, including approximately 300 million ounces of silver, 8 million tonnes of zinc and 8 million tonnes of lead.

Notably, geophysical data suggests that Kootenay Zinc's Sully project and Sullivan share many geological features:

  • Strata at Sully are in the same sedimentary basin as the Sullivan mine
  • The exact stratigraphic time horizon at which Sullivan formed is present at Sully
  • Filtered AeroMag anomalies coincident with Sullivan Time at Sully appear similar to Sullivan
  • Gravity anomaly at Sully indicates excess mass of comparable magnitude to Sullivan
  • Pb-Zn is present as traces in outcrop, drill core and in a soil geochemical anomaly

The squeeze in zinc supplies particularly affects China, which is both the world's largest zinc consumer and its largest producer, with 4.9 million tons of output in 2015. Chinese manufacturers are now being forced to import zinc for use in cars, household appliances, paints, rubber products and smartphones.

Zinc's rally shows no sign of slowing down in the near future, and companies that currently occupy stake in a zinc deposit find themselves in an enviable position over miners rushing to find new reserves. With its Sully Project, Kootenay Zinc could be on track to capture its share of the market, guided by a management team of mining directors and executives that currently lead some of the world's best mining companies and have been involved in world-class discoveries which sold for billions of dollars. The company's technical team includes industry experts that have worked on mega-mining projects, including the Sullivan and Voisey Bay projects. Disclaimer

Kootenay Zinc Corp. Company Blog

Kootenay Zinc Corp. News:

Kootenay Zinc Corp.: Sully Project Exploration Update

NetworkNewsWire Releases Exclusive Audio Interview with Kootenay Zinc Corp. (KTNNF)

NetworkNewsWire Announces Publication on the Bullish Outlook for Zinc and the Companies Set to Profit

Patriot One Technologies, Inc. (PTOTF)

The QualityStocks Daily Newsletter would like to spotlight Patriot One Technologies, Inc. (PTOTF). Today, Patriot One Technologies, Inc. closed trading at $0.59, up 7.66%, on 59,876 volume with 36 trades. The stock’s average daily volume over the past 60 days is 81,773, and its 52-week low/high is $0.4665/$1.49.

Patriot One Technologies, Inc. (PTOTF) is leveraging seven years of development to create powerful technologies that mitigate security risks by detecting concealed weapons via novel radar technology.

Developed through a NATO-funded project at McMaster University, Patriot One's disruptive NForce CMR1000 technology is the first cost-effective solution available for active shooter prevention, the need for which is evidenced by an increasing number of active shooter events in the United States and worldwide.

A recent study that surveyed data going back as far as 1966 demonstrates that there have been significantly more mass shootings in the U.S. than any other country for decades. Statistics for the 46-year period shows that even though America only holds 5% of the world's population, it took count of 31% of all public mass shootings. According to the FBI, there were an astounding 160 incidents from 2000 to 2013 that resulted in 486 people killed and 557 wounded. In years 2014 and 2015, there were nearly six times as many incidents compared to 2000 and 2001. The disturbing trend shows that there will be increasingly more incidents if better preventative measures aren't taken.

Patriot One's patent-pending solution to this alarming progression enables stand-off detection, even on moving targets, with a "cognitive" ability to learn and identify new threats once deployed. The product is not intended to threaten the constitutional rights of legal gun carriers, and it is also void of privacy and health concerns of traditional detection technologies, which require subject compliance, present false positives, and are often slow, inefficient and costly.

In contrast, Patriot One's technology is small in size and can be "covertly" placed in a doorway or hallway to prevent planned attacks in public places like schools, concerts, stadiums, banks, airports, offices, hospitals, shopping centers and other facilities for which there are concerns. With this method of deployment, there is no subject compliance requirement. In addition, because an image of the target is not generated, there are also no privacy concerns. Detection is real-time and entirely computer-based, which means there is no need for human operators to alert security. This eliminates the safety concerns of a would-be operator, reduces the expense of a human operator, and enables overall accuracy of 93%.

The technology is designed to identify if someone is carrying a gun, knife, suicide vest, etc., by analyzing metal content and relating it to a database of known weapon signatures. Patriot One believes the widespread use of this detection technology could act as an effective deterrent, thereby diminishing the epidemic phenomena of active shooters across the nation and around the world.

The company is guided by a team of experts in the areas of high-frequency electromagnetics, counter-terrorism, conflict resolution, government/corporate interface, sensor development, proactive security and business development. Senior Management has partnered with, among other affiliates, Ridge Global, which was founded by recently appointed advisory board member Tom Ridge, the first head of the Department of Homeland Security, first U.S. Secretary of Homeland Security, and 43rd governor of Pennsylvania.

Along with its partners, Patriot One is addressing global concerns of active shooting events and other violent terrorist attacks. The key is to short-circuit the event through effective prevention technologies and security protocols. Disclaimer

Patriot One Technologies, Inc. Company Blog

Patriot One Technologies, Inc. News:

Patriot One Marks 3-Months of Global PATSCAN Sales with $2.7M in Signed Agreements

Patriot One Appoints Former Senior Counter Terrorism Official John Gillies to Board

Patriot One and SENGEX Accelerate PATSCAN Delivery to U.S. Government Agencies

Grey Cloak Tech, Inc. (GRCK)

The QualityStocks Daily Newsletter would like to spotlight Grey Cloak Tech, Inc. (GRCK). Today, Grey Cloak Tech, Inc. closed trading at $0.079, up 7.48%, on 8,950 volume with 3 trades. The stock’s average daily volume over the past 60 days is 44,675, and its 52-week low/high is $0.025/$0.605.

Grey Cloak Tech, Inc. (GRCK) is a developer of industry-leading click-fraud detection software designed to overcome the most expensive and devastating threats in the digital world. Through its recently acquired subsidiary, ShareRails, Grey Cloak now also provides sophisticated e-commerce tools that help retailers evolve beyond their brick-and-mortar business practices to increase both their digital engagement and their foot traffic.

ShareRails is an online-to-offline technology firm that provides vitally important services within the trillion-dollar retail sector, helping brick-and-mortar retailers compete directly for online awareness with e-commerce-only brands. Through the ShareRails O2O platform, offline retailers can use online channels to more effectively drive sales and attract new customers.

The innovative solutions offered by ShareRails enable local retailers to capture the millions of online shopping searches they are currently missing out on because their product inventories and other key information is not currently available online and, therefore, does not appear in relevant searches and cannot be viewed digitally.

Most of today's retail sales are Web-influenced. By utilizing digital marketing channels, merchants can enhance the in-store shopping experience for customers and simultaneously boost sales. The ShareRails O2O platform enables retailers to put their product catalogs online, along with product location and availability, and make the information searchable. The platform also offers digital merchandising tools that include an outfit builder and wishlist app along with conversational shopping tools. Through ShareRails O2O, merchants can additionally tap into data that details shopper insights and behavioral trends. Add-on services include click-n-collect, reservations for in-store pickup, and local delivery.

ShareRails additionally offers Dress.li, which is a recommendation and reward platform that connects shoppers to stylists, bloggers and other fashion influencers who provide them with expert shopping advice and uniquely styled looks and, simultaneously, connects the consumers to fashion retailers. Through Dress.li, the challenge of creating a seamless social shopping experience has finally been mastered! This platform facilitates live shopping communications, curation and content creation and lets users join a global network of trendsetters. Through this network, users can inspire and be inspired, accessing and sharing product recommendations and unique looks and receiving rewards each time another user makes a purchase from their recommendations. This platform not only provides an enjoyable and exciting network for shoppers and fashionistas, but it simultaneously supplies retailers with a lucrative outlet for acquiring new customers through a built-in global sales force of fashion influencers. As these Dress.li stylists create and share looks, they also deliver pre-qualified sales leads and conversions and are rewarded for doing so.

Joined together, Grey Cloak Tech's industry-leading click-fraud detection solutions and the exciting retail-boosting products delivered through ShareRails offer a broad package of services to both protect businesses in the digital world and help them utilize digital channels to bolster their sales and enhance customer engagement.

Grey Cloak Tech continues to serve as an industry leader in developing the most effective and comprehensive weapons to fight online security threats. The company is keenly focused on protecting its clients' interests through the identification of fraud patterns at the very earliest stages. When businesses partner with Grey Cloak Tech, they can look forward to benefiting from industry-leading technology, a top-tier client services team, and an augmented bottom line. Disclaimer

Grey Cloak Tech, Inc. Company Blog

Grey Cloak Tech, Inc. News:

Grey Cloak Tech's ShareRails Launches first Searchable Mall for Pacific Retail Capital Partners, Allowing Consumers to Find Online and Buy In Store

Grey Cloak Tech Completes the Acquisition of ShareRails O2O E-commerce Services Platform

Grey Cloak Tech, Inc. (GRCK) is “One to Watch”

InMed Pharmaceuticals, Inc. (IMLFF)

The QualityStocks Daily Newsletter would like to spotlight InMed Pharmaceuticals, Inc. (IMLFF). Today, InMed Pharmaceuticals, Inc. closed trading at $0.2862, up 2.21%, on 190,966 volume with 119 trades. The stock’s average daily volume over the past 60 days is 1,037,974, and its 52-week low/high is $0.05/$0.72.

InMed Pharmaceuticals, Inc. (IMLFF) is a preclinical-stage biopharmaceutical company specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. Utilizing its proprietary bioinformatics assessment tool, InMed aims to identify bioactive compounds found within the cannabis plant that have the potential to offer optimized therapeutic benefit while demonstrating limited adverse effects. This assessment tool, in combination with the company’s cannabinoid biosynthesis technology and drug development pipeline, serves as InMed’s fundamental value driver.

Bioinformatics is a proprietary, computer-based program designed to assist in the identification of novel cannabinoids using comprehensive algorithms to integrate data from numerous bioinformatics databases, as well as a database on the structure of currently approved pharmaceutical products and an extensive database on over 90 individual cannabinoid drugs found in cannabis. This extensive collection of data is derived from both public and propriety-based sources. Leveraging this tool, the company aims to create associations between approved pharmaceuticals and cannabinoids with similar structures in order to identify active cannabinoids that have the potential to treat specific diseases. Per InMed’s website, this type of bioinformatics assessment represents “significant promise for future drug discovery, as it integrates many data sets and builds holistic models to approach a specific disease.”

After discovering these promising active cannabinoids, InMed moves to test and confirm their activity in biological systems through in vitro and in vivo experimentation. It is at this stage of development that the company’s proprietary biosynthesis process of cannabinoid manufacturing will be most promising. InMed is currently developing a robust, high-yield biosynthesis process for manufacturing all 90+ naturally-occurring cannabinoids. By modifying the agriculture-based formula for harvesting cannabinoids, InMed aims to combine the inherent safety and known efficacy of the natural drug structure with the convenience, control and quality of 21st Century laboratory-based manufacturing processes.

The company’s pipeline currently includes two drug candidates in preclinical development, including INM-750 for the treatment of epidermolysis bullosa (EB) and INM-085 for the treatment of glaucoma. Referred to by the Dystrophic Epidermolysis Bullosa Research Association of America as “The Worst Disease You’ve Never Heard Of,” EB is a rare genetic connective tissue disorder that affects roughly one out of every 20,000 births in the United States. The condition currently has no approved treatment or cure. Through the development of INM-750, InMed is attempting to address this significant unmet medical need. The drug candidate replaces missing keratins in the skin with specially selected cannabinoids in an effort to modulate the painful manifestations of EB.

INM-085, InMed’s second development candidate, is formulated to reduce the elevated intra-ocular pressure that is often associated with glaucoma. Additionally, the cannabinoids utilized in INM-085 are expected to provide neuroprotection for the retinal ganglion cells and other optic nerve tissues following topical administration. Although it is still in preclinical development, INM-085 targets a sizable market. According to the Glaucoma Research Foundation, glaucoma is a leading cause of blindness with no approved cure. The National Institutes of Health estimates that more than 3 million Americans currently have glaucoma, and more than 120,000 have been blinded by the disease.

InMed is focused on progressing toward validation of its drug candidate selection, using data to secure its patents and developing key disruptive technologies. In 2016, the company was successful in completing financings of $1.9 million. In January 2017, InMed completed a non-brokered private placement of common shares generating aggregate gross proceeds of C$1.5 million, strongly positioning the company to attract the new investment required to fund its aggressive growth strategies in 2017.

The company’s management team has well over a century of combined experience in the biopharmaceutical space. Company CEO Eric Adams has more than 25 years of experience in company and capital formation, global market development, mergers and acquisitions, licensing and corporate governance. During his time as CEO of enGene Inc., he led the gene therapy startup to a position at the head of the industry.

Joining Adams on the InMed management team are Chief Scientific Officer Dr. Sazzan Hossain; Senior Vice President, Clinical and Regulatory Affairs Alexandra D.J. Mancini; SVP, Corporate Strategy & Investor Relations Chris Bogart; and Chief Financial Officer Jeff Charpentier, as well as Chief Medical Officer Dr. Ado Muhammed, MD, DPM, MFPM.

Muhammed, in particular, has an extensive history in the pharmaceutical industry, having previously served as an executive of GW Pharmaceuticals, a global leader in the development of cannabinoid-based medicines. During his time as Associate Medical Director of that company, Muhammed played an instrumental role in the development and FDA approval of one of the first cannabis drugs. This GW Pharmaceuticals development program coincided with a sharp rise in share price from less than $9 in 2013 to more than $129 today, with the company’s current market value totaling more than $2.9 billion. Disclaimer

InMed Pharmaceuticals, Inc. Company Blog

InMed Pharmaceuticals, Inc. News:

InMed Pharma Advances Toward Clinical Trials with CRO Deal -- CFN Media

InMed Announces Agreement to Advance a Topical Formulation of INM-750

InMed Raises $5.75 Million Through Underwritten Financing Including Full Exercise of the Over-Allotment Option

Players Network, Inc. (PNTV)

The QualityStocks Daily Newsletter would like to spotlight Players Network, Inc. (PNTV). Today, Players Network, Inc. closed trading at $0.115, up 0.88%, on 3,253,419 volume with 215 trades. The stock’s average daily volume over the past 60 days is 2,843,409, and its 52-week low/high is $0.0023/$0.1315.

Players Network, Inc. (PNTV) is a diversified holding company operating in marijuana and media. PNTV owns 86% of Green Leaf Farms Holdings, LLC (Green Leaf Farms) which has Nevada state-issued cultivation and production license(s). The cultivation license enables Green Leaf Farms to grow marijuana and the production license enables them to create extracts which are used for cartridges, oils and edibles. WeedTV.com is a wholly owned subsidiary which is developing the ultimate resource for the marijuana lifestyle. PNTV has been a fully reporting, publicly traded company since 1998.

Green Leaf Farms Holdings, LLC (Green Leaf)

Green Leaf produces medical and recreational cannabis products. Revenues are generated by selling their cannabis products to licensed dispensaries throughout Nevada.

Their mission is to produce the highest quality and safest pharmaceutical-grade cannabis to all levels of consumers. They utilize the most efficient cultivation methods in order to lower expenses for consumers and to maximize returns for investors.

They are a privately held company with a unique business model as they are one of only a few companies who have been granted 2 (two) Medical Marijuana Establishment (MME) licenses in Nevada; Cultivation and Production.

Their Cultivation License enables them to grow cannabis which will produce flower. Their Production License enables them to process flower (cannabis) and cannabis byproducts into extremely pure concentrates, extracts, and oils which are used in medicine, cartridges and edibles. Green Leaf has both acquired and developed proprietary cannabis strains and will continue to be committed to cannabis research and development.

Green Leaf is located in North Las Vegas, Nevada on 2.3 acres in a state-of-the-art 26,000 sq. ft. facility. They have a seasoned team of professional growers and operators to manage the facility with proven best practices to ensure they have the highest quality products available.


WeedTV.Com is a niche social network and lifestyle channel destination for the marijuana industry. They are developing the "go-to" source for information, entertainment, products and services for people who relate to the marijuana lifestyle and an active social community. WeedTV.com features daily stories sourced by WeedTV.com correspondents and contributors from around the world.

Programming includes, political news, business news on the industry, financial analysis from industry experts, growing tips, cooking tips, the "Weed101" section, medical applications/issues, lifestyle features, and entertainment specials.

WeedTV.com's first original series is titled "High Stakes." High Stakes was developed by Michael Berk, the company's Chief Creative Officer and creator of one of the most popular cable series of all time, Baywatch. High Stakes is docu-series that follows the team at Green Leaf Farms as they build their facility and launch their marijuana business.

By leveraging media, WeedTV.com builds long-term brand equity and connects consumers to businesses. This is accomplished through fresh and relevant content such as professionally produced branded television segments, user-generated videos, blogs, editorials, tweets (twitter), photos, special offers, events and custom-designed contests to engage both consumers and businesses with their brands and services.

Marijuana and Media Strategy

While developing WeedTV.com, the PNTV team realized they could implement a vertical strategy to utilize their media platform (WeedTV.com) to drive business and awareness to their cannabis products (Green Leaf Farms). Through the audience and reach of WeedTV.com, they will build brand value and cross market their own marijuana products, as well as generate revenues by marketing other companies' products and services. Disclaimer

Players Network, Inc. Company Blog

Players Network, Inc. News:

Player's Network, Inc. Appoints Geoffrey Lawrence, Nevada Assistant State Controller, as Chief Financial Officer, Chief Compliance Officer

Player's Network, Inc. CEO Featured on MoneyTV with Donald Baillargeon, 6/2

Player's Network, Inc. Subsidiary Awarded Two Nevada Recreational Marijuana Licenses


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



Trader Power News
(MYO) +60.56%


MarketClub Analysis
(CLSN) +56.10%


(HOS) +34.01%

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251